Probiotic supplementation decreases intestinal transit time: Meta-analysis of randomized controlled trials

被引:67
作者
Miller, Larry E. [1 ]
Ouwehand, Arthur C. [2 ]
机构
[1] Miller Sci Consulting Inc, Arden, NC 28704 USA
[2] DuPont Nutr & Hlth, FIN-02460 Kantvik, Finland
关键词
Constipation; Gastrointestinal; Intestinal transit time; Meta-analysis; Probiotics; FUNCTIONAL GASTROINTESTINAL DISORDERS; IRRITABLE-BOWEL-SYNDROME; FERMENTED MILK; DOUBLE-BLIND; RYE BREAD; CONSTIPATION; SYMPTOMS; PRODUCT; YOGURT; WOMEN;
D O I
10.3748/wjg.v19.i29.4718
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To determine the efficacy of probiotic supplementation on intestinal transit time (ITT) and to identify factors that influence these outcomes. METHODS: A systematic review of randomized controlled trials (RCTs) of probiotic supplementation that measured ITT in adults was conducted by searching MEDLINE and EMBASE using relevant key word combinations. Main search limits included RCTs of probiotic supplementation in healthy or constipated adults that measured ITT. Study quality was assessed using the Jadad scale. A random effects meta-analysis was performed with standardized mean difference (SMD) of ITT between probiotic and control groups as the primary outcome. Meta-regression and subgroup analyses were conducted to examine the impact of moderator variables on ITT SMD. RESULTS: A total of 11 clinical trials with 13 treatment effects representing 464 subjects were included in this analysis. Probiotic supplementation was associated with decreased ITT in relation to controls, with an SMD of 0.40 (95%CI: 0.20-0.59, P < 0.001). Constipation (r(2) = 39%, P = 0.01), higher mean age (r(2) = 27%, P = 0.03), and higher percentage of female subjects (r(2) = 23%, P < 0.05) were predictive of decreased ITT with probiotics in meta-regression. Subgroup analyses demonstrated statistically greater reductions in ITT with probiotics in subjects with vs without constipation and in older vs younger subjects [both SMD: 0.59 (95%CI: 0.39-0.79) vs 0.17 (95%CI: -0.08-0.42), P = 0.01]. Medium to large treatment effects were identified with Bifidobacterium Lactis (B. lactis) HN019 (SMD: 0.72, 95%CI: 0.27-1.18, P < 0.01) and B. lactis DN-173 010 (SMD: 0.54, 95%CI: 0.15-0.94, P < 0.01) while other single strains and combination products yielded small treatment effects. CONCLUSION: Overall, short-term probiotic supplementation decreases ITT with consistently greater treatment effects identified in constipated or older adults and with certain probiotic strains. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:4718 / 4725
页数:8
相关论文
共 28 条
[1]   Guidance on the scientific requirements for health claims related to gut and immune function EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) [J].
Agostoni, Carlo ;
Bresson, Jean-Louis ;
Fairweather-Tait, Susan ;
Flynn, Albert ;
Golly, Ines ;
Korhonen, Hannu ;
Lagiou, Pagona ;
Lovik, Martinus ;
Marchelli, Rosangela ;
Martin, Ambroise ;
Moseley, Bevan ;
Neuhaeuser-Berthold, Monika ;
Przyrembel, Hildegard ;
Salminen, Seppo ;
Sanz, Yolanda ;
Strain, Sean ;
Strobel, Stephan ;
Tetens, Inge ;
Tome, Daniel ;
van Loveren, Hendrik ;
Verhagen, Hans .
EFSA JOURNAL, 2011, 9 (04)
[2]   Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation [J].
Agrawal, A. ;
Houghton, L. A. ;
Morris, J. ;
Reilly, B. ;
Guyonnet, D. ;
Feuillerat, N. Goupil ;
Schlumberger, A. ;
Jakob, S. ;
Whorwell, P. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) :104-114
[3]   Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation [J].
Ansari R. ;
Sohrabi S. ;
Ghanaie O. ;
Amjadi H. ;
Merat S. ;
Vahedi H. ;
Khatibian M. .
Indian Journal of Gastroenterology, 2010, 29 (2) :66-68
[4]   DOES YOGURT ENRICHED WITH BIFIDOBACTERIUM-LONGUM AFFECT COLONIC MICROBIOLOGY AND FECAL METABOLITES IN HEALTHY-SUBJECTS [J].
BARTRAM, HP ;
SCHEPPACH, W ;
GERLACH, S ;
RUCKDESCHEL, G ;
KELBER, E ;
KASPER, H .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 59 (02) :428-432
[5]  
Bouvier M., 2001, Bioscience and Microflora, V20, P43
[6]   Systematic review of randomised controlled trials: Probiotics for functional constipation [J].
Chmielewska, Anna ;
Szajewska, Hania .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (01) :69-75
[7]  
Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[8]   UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[9]   The functional gastrointestinal disorders and the Rome III process [J].
Drossman, Douglas A. .
GASTROENTEROLOGY, 2006, 130 (05) :1377-1390
[10]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634